DiseaseID 6251
髓样癌
disease
NCI2016_02D:A term referring to medullary carcinomas which can develop in various anatomic sites such as the thyroid gland, breast, colon, rectum, and small intestine.|MSH2017_2016_08_12:A carcinoma composed mainly of ep
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Disease: 1Symptom: 4Target: 12Links: 16
Arranging relationship network...
Record Fields
Scalar fields from the final disease record.
- Disease Id
- 6251
- Core Entity Id
- 62875
- Source Entity Count
- 1
- Preferred Name
- Medullary Carcinoma
- Name Cn
- 髓样癌
- Name Pinyin
- Sui Yang Ai
- Name En
- Medullary Carcinoma
- Name Latin
- Bilingual Status
- complete
- Disease Type
- disease
- Umls Disease Type
- Neoplastic Process
- Disgenet Type
- disease
- Mesh Class
- NeoplasmsNeoplasms; Endocrine System Diseases
- Do Class
- disease of anatomical entity; disease of cellular proliferation
- Hpo Class
- Neoplasm; Abnormality of the endocrine system
- Mesh Class Name
- NeoplasmsNeoplasms; Endocrine System Diseases
- Hpo Class Name
- Abnormality of the endocrine system; Neoplasm
- Do Class Name
- disease of anatomical entity; disease of cellular proliferation
- Disease Definition
- NCI2016_02D:A term referring to medullary carcinomas which can develop in various anatomic sites such as the thyroid gland, breast, colon, rectum, and small intestine.|MSH2017_2016_08_12:A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%-7% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%-10% of all thyroid malignancies. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1141; Segen, Dictionary of Modern Medicine, 1992)
- Version
- v2
- Suppressed
- No
Names
Preferred names, aliases, and source labels retained in the final schema.
Name
Medullary Carcinoma
Role
preferred
Name
Medullary Carcinoma Of Thyroid
Role
preferred
Name
Carcinoma, Medullary
Role
alias
Name
Medullary Thyroid Cancer
Role
alias
Name
Medullary Thyroid Carcinoma
Role
alias
Name
Thyroid Cancer, Medullary
Role
alias
Name
Thyroid Carcinoma, Medullary
Role
alias
Name
Thyroid Gland Medullary Carcinoma
Role
alias
Cross References
Trusted external identifiers retained for this final record.
Hpo
HP:0002865
Herb
HBDIS004424HBDIS005182
Me Sh
D018276
Umls
C0206693C0238462
Sym Map
SMDE10796SMDE10798
Do Class
DOID:14566DOID:7
Dis Ge Net
C0206693C0238462
Umls Sty
T191
Hpo Class
HP:0000818HP:0002664
Me Sh Class
C04C19
Tcmbank Disease
1655923938
Attributes
Merged source attributes and domain-specific metadata.
Version
v2
Suppress
0
Do Class Name
disease of anatomical entity; disease of cellular proliferation
Disease Type
disease
Hpo Class Name
Abnormality of the endocrine system; Neoplasm
Do Disease Class
disease of anatomical entity; disease of cellular proliferation
Hpo Disease Class
Neoplasm; Abnormality of the endocrine system
Umls Disease Type
Neoplastic Process
Disease Definition
NCI2016_02D:A term referring to medullary carcinomas which can develop in various anatomic sites such as the thyroid gland, breast, colon, rectum, and small intestine.|MSH2017_2016_08_12:A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%-7% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%-10% of all thyroid malignancies. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1141; Segen, Dictionary of Modern Medicine, 1992)NCI2016_NCI-GLOSS_1602D:Cancer that develops in C cells of the thyroid. The C cells make a hormone (calcitonin) that helps maintain a healthy level of calcium in the blood.|NCI2016_CDISC_1602D:A neuroendocrine malignant epithelial neoplasm arising from C-cells of the thyroid gland.|NCI2016_02D:A neuroendocrine carcinoma arising from the C-cells of the thyroid gland. It is closely associated with multiple endocrine neoplasia syndromes. Approximately 10% to 20% of medullary thyroid carcinomas are familial. Patients usually present with a thyroid nodule that is painless and firm. In the majority of cases nodal involvement is present at diagnosis. Surgery is the preferred treatment for both primary lesions and recurrences. This carcinoma is generally not very sensitive to radiation and almost unresponsive to chemotherapy.|HPO2016_07_04:The presence of a medullary carcinoma of the thyroid gland. [HPO:probinson]|CSP2006:two types are found, familial and sporadic; if familial, the carcinoma is bilateral and may be associated with other benign or malignant endocrine organ tumors; if sporadic, it is unilateral; thyroidectomy and radiation therapy are treatments of choice.
Me Sh Disease Class
NeoplasmsNeoplasms; Endocrine System Diseases
Dis Ge Net Disease Type
disease
Disease Class Name Me Sh
NeoplasmsNeoplasms; Endocrine System Diseases
Umls Semantic Type Name
Neoplastic Process